Medical Research Articles Published in January 2012

With a Free Docphin Account, you create a custom list of medical research journal sources that are easy to navigate, search our extensive databse of articles, save and organize your articles into folders, set up alerts to be notificed of research articles that match your interests ... and much more.

Login or Register
01/01/2012
A videoconferencing tool acting as a home-based healthcare monitoring robot for elderly patients. (PubMedID: 23138093) Studies in health technology and informatics
01/01/2012
Telemonitoring of medication adherence in patients with major mental illness: watching the patient as well as the pills. (PubMedID: 23138094) Studies in health technology and informatics
01/01/2012
The university hospital. (PubMedID: 23484424) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Is there a role for academic medical centers in emerging markets? (PubMedID: 23484425) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
The role of public university hospitals in a globalized world. (PubMedID: 23484426) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
The internationalization of health care: the UZ Brussel model for international partnerships. (PubMedID: 23484427) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Hospital quality management: the perspective of a Belgian academic medical center. (PubMedID: 23484428) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
The interdependence of productivity, cost, and outcome: studies of service delivery in Finnish university hospitals. (PubMedID: 23484429) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
The university hospital as a hub for connected health: Oulu Healthworld, Northern Scandinavia. (PubMedID: 23484430) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
United States academic medical centers: priorities and challenges amid market transformation. (PubMedID: 23484431) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Successfully leading change: innovation in service delivery. (PubMedID: 23484432) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
The private hospital sector. (PubMedID: 22913121) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
The risks and opportunities of the globalization of health care delivery. (PubMedID: 22913122) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Global implications from the US hospitals privatization experience. (PubMedID: 22913123) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Collaborating to improve the global competitiveness of US academic medical centers. (PubMedID: 22913124) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
A zebra or a painted horse? Are hospital PPPs infrastructure partnerships with stripes or a separate species? (PubMedID: 22913125) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
The role of Public Private Partnership: the Brazilian experience of modernizing hospitals in the São Paulo Prefecture Health Secretariat. (PubMedID: 22913126) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
The African Health Fund and Nairobi Women's Hospital--a successful model for improving access to capital for health businesses. (PubMedID: 22913127) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Report of a recent "brake" through in the fiber burden-mesothelioma dialogue. (PubMedID: 22283446) Inhalation toxicology
01/01/2012
Letter re Marsh et al. (PubMedID: 22283448) Inhalation toxicology
01/01/2012
Quality improvement activity in radiology reading and reporting in a rural setting hospital in Indonesia. (PubMedID: 22913128) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Apollo Quality Program. (PubMedID: 22913129) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Think globally, act locally. (PubMedID: 23016194) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
International patients in a Turkish hospital: a quantitative study on cross-border health care at the intersection of Eastern Europe, Asia and the Middle East. (PubMedID: 23016195) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
World Trade Organization activity for health services. (PubMedID: 23016196) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Integration of hospitals: is it time for similar changes in Georgia? (PubMedID: 23016197) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Information technology orientation for young hospital administrators. (PubMedID: 23016198) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Using a contribution margin system to manage medical centers in Berlin. (PubMedID: 23016199) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Stress, health and satisfaction of Australian and German doctors--a comparative study. (PubMedID: 23016200) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Improved use of allied health professionals in the health care system: the case of the advanced practice physiotherapist in orthopedic care. (PubMedID: 23016201) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
A five-year prevalence study of burn injury in a Nigerian teaching hospital. (PubMedID: 23016202) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Leadership and management through financial crisis and uncertainty. (PubMedID: 23342752) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Managing the myths of health care. (PubMedID: 23342753) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Health leadership and management competencies: a systemic approach. (PubMedID: 23342754) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Leadership and globalization: research in health management education. (PubMedID: 23342755) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Leadership and management quality: key factors in effective health systems. (PubMedID: 23342756) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Health and hospital reform in Australia--a local health district's perspective. (PubMedID: 23342757) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Current situation of health care in India and corporation in emerging economies--what is the way forward? (PubMedID: 23342758) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Credentialing for health care leaders: an overview of ACHE's FACHE credential and its contributions to the health care management field. (PubMedID: 23342759) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Is leadership compatible with hospitals? Lessons from 10 years of teaching leadership to hospital managers. (PubMedID: 23342760) World hospitals and health services : the official journal of the International Hospital Federation
01/01/2012
Regional particle size dependent deposition of inhaled aerosols in rats and mice. (PubMedID: 22145784) Inhalation toxicology
01/01/2012
Computational estimation of errors generated by lumping of physiologically-based pharmacokinetic (PBPK) interaction models of inhaled complex chemical mixtures. (PubMedID: 22149415) Inhalation toxicology
01/01/2012
Transcriptional activation of inflammasome components by Libby amphibole and the role of iron. (PubMedID: 22168577) Inhalation toxicology
01/01/2012
Nasal epithelial lesions in F344 rats following a 90-day inhalation exposure to naphthalene. (PubMedID: 22182220) Inhalation toxicology
01/01/2012
Development of a physiologically based pharmacokinetic model for inhalation of jet fuels in the rat. (PubMedID: 22188408) Inhalation toxicology
01/01/2012
A new time-series methodology for estimating relationships between elderly frailty, remaining life expectancy, and ambient air quality. (PubMedID: 22214527) Inhalation toxicology
01/01/2012
Effects on airways of short-term exposure to two kinds of wood smoke in a chamber study of healthy humans. (PubMedID: 22220980) Inhalation toxicology
01/01/2012
Considerations for the design and technical setup of a human whole-body exposure chamber. (PubMedID: 22229735) Inhalation toxicology
01/01/2012
Nanoparticles: a review of particle toxicology following inhalation exposure. (PubMedID: 22260506) Inhalation toxicology
01/01/2012
A case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: effect of upper airway morphology and comparison with in vivo data. (PubMedID: 22260527) Inhalation toxicology
01/01/2012
Biological responses in rats exposed to cigarette smoke and Middle East sand (dust). (PubMedID: 22283445) Inhalation toxicology
01/01/2012
The SEA (Social cognition and Emotional Assessment): a clinical neuropsychological tool for early diagnosis of frontal variant of frontotemporal lobar degeneration. (PubMedID: 21895376) Neuropsychology
01/01/2012
Deficits of contralesional awareness: a case study on what paper-and-pencil tests neglect. (PubMedID: 21895377) Neuropsychology
01/01/2012
Time since stroke influences the impact of hemianopia and spatial neglect on visual-spatial tasks. (PubMedID: 21966887) Neuropsychology
01/01/2012
Atypical brain oscillations: a biological basis for dyslexia? (PubMedID: 22197212) Trends in cognitive sciences
01/01/2012
Insights for treatment in Tourette syndrome from fMRI. (PubMedID: 22133579) Trends in cognitive sciences
01/01/2012
Therapygenetics: moving towards personalized psychotherapy treatment. (PubMedID: 22104133) Trends in cognitive sciences
01/01/2012
Human rights and health systems development: confronting the politics of exclusion and the economics of inequality. (PubMedID: 23568941) Health and human rights
01/01/2012
Associations between human rights environments and healthy longevity: the case of older persons in China. (PubMedID: 23568942) Health and human rights
01/01/2012
How do national strategic plans for HIV and AIDS in southern and eastern Africa address gender-based violence? A women's rights perspective. (PubMedID: 23568943) Health and human rights
01/01/2012
Technology, conflict early warning systems, public health, and human rights. (PubMedID: 23568944) Health and human rights
01/01/2012
Integrating interventions on maternal mortality and morbidity and HIV: a human rights-based framework and approach. (PubMedID: 23568945) Health and human rights
01/01/2012
Policy reform to shift the health and human rights environment for vulnerable groups: the case of Kyrgyzstan's Instruction 417. (PubMedID: 23568946) Health and human rights
01/01/2012
Access to health care for undocumented migrants from a human rights perspective: a comparative study of Denmark, Sweden, and The Netherlands. (PubMedID: 23568947) Health and human rights
01/01/2012
Land security and the challenges of realizing the human right to water and sanitation in the slums of Mumbai, India. (PubMedID: 23568948) Health and human rights
01/01/2012
Lead poisoning in China: a health and human rights crisis. (PubMedID: 23568949) Health and human rights
01/01/2012
[Evaluation of TB-beads assay utilizing the technique of magnetic beads--an innovative assay method for detection of acid fast bacilli]. (PubMedID: 23547479) Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology
01/01/2012
[Investigation on the identification accuracy for group B Streptococcus by automated identification system RAISUS]. (PubMedID: 23547480) Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology
01/01/2012
[Pandemic influenza]. (PubMedID: 23547481) Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology
01/01/2012
[Applications of MALDI-TOF mass spectrometry in today's and tomorrow's clinical microbiology laboratory]. (PubMedID: 23547482) Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology
01/01/2012
[Infectious disease after the great Hanshin-Awaji earthquake and the contribution of rapid diagnosis in microbiology]. (PubMedID: 23547483) Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology
01/01/2012
[Contribution of the rapid diagnostic tests for infectious diseases to the patient management in the Great East Japan earthquake]. (PubMedID: 23547484) Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology
01/01/2012
[Risk management in a microorganism test room]. (PubMedID: 23547485) Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology
01/01/2012
[Respiratory Viral Panel Detection Kit and Gastrointestinal Pathogen Panel Detection Kit using Luminex technology]. (PubMedID: 23547486) Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology
01/01/2012
Prospective memory after moderate-to-severe traumatic brain injury: a multinomial modeling approach. (PubMedID: 21988127) Neuropsychology
01/01/2012
Reduced susceptibility to the attentional blink in psychopathic offenders: implications for the attention bottleneck hypothesis. (PubMedID: 22023489) Neuropsychology
01/01/2012
Dual task performance of working memory and postural control in major depressive disorder. (PubMedID: 22059649) Neuropsychology
01/01/2012
Deconstructing spatial working memory and attention deficits in multiple sclerosis. (PubMedID: 22059650) Neuropsychology
01/01/2012
Does attentional training improve numerical processing in developmental dyscalculia? (PubMedID: 22081984) Neuropsychology
01/01/2012
Numeracy skills in patients with degenerative disorders and focal brain lesions: a neuropsychological investigation. (PubMedID: 22122516) Neuropsychology
01/01/2012
Mood and motor trajectories in Parkinson's disease: multivariate latent growth curve modeling. (PubMedID: 22142359) Neuropsychology
01/01/2012
Changes in response bias with different study-test delays: evidence from young adults, older adults, and patients with Alzheimer's disease. (PubMedID: 22409339) Neuropsychology
01/01/2012
Examining frontotemporal connectivity and rTMS in healthy controls: implications for auditory hallucinations in schizophrenia. (PubMedID: 22409340) Neuropsychology
01/01/2012
[Effects of different altitudes on cardiac hemodynamics and electrocardiogram of healthy male adults]. (PubMedID: 22493881) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Effect of swimming exercise on the expression of apelin and its receptor in pulmonary tissues of rats with hypoxic pulmonary hypertension]. (PubMedID: 22493882) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[The role of nitric oxide in ethanol postconditioning induced cardioprotection]. (PubMedID: 22493883) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Effect of alcohol exposure during pregnancy on learning and memory and expression of cdk5 in the hippocampus of infant rats]. (PubMedID: 22493884) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Cis-CA1P inhibits tumor cell proliferation and prevents blood vessel formation]. (PubMedID: 22493885) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Effect of butylphthalide on levels of glutamate and expression of NR2B in the hippocampus of rats with alcohol addiction]. (PubMedID: 22493886) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[The effect of the magnesium supplementation on vascular calcification in rats]. (PubMedID: 22493887) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Nicotine regulates large conductance ca2+ activated K+ channels in rat coronary arterial smooth muscle cells]. (PubMedID: 22493888) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Cardioprotective effects of limb ischemic postconditioning by different strength and time in rabbits]. (PubMedID: 22493889) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Study of DiBAC4(3) for dynamic measurement of embryo membrane potentials]. (PubMedID: 22493890) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Experimental study on the glutamine's intervention effect on the opening of permeability transition pore in myocardial mitochondrial membrane]. (PubMedID: 22493891) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Effect of hyperbaric oxygen on the expression of nitric oxide synthase mRNA in cortex after acute traumatic cerebral injury]. (PubMedID: 22493892) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Therapeutic efficacy of hyperbaric oxygen on traumatic brain injury in the rat and the underlying mechanisms]. (PubMedID: 22493893) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Effect of electrical stimulation of the entopeduncular nucleus on the neuronal activities of pedunculopontine nucleus in rats]. (PubMedID: 22493894) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[The role of the spinal cord inducible nitric oxide synthase in morphine dependence and naloxone-precipitated withdrawal rats]. (PubMedID: 22493895) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Influence of salidroside from Rhodiola Sachalinensis A. Bor on some related indexes of free radical and energy metabolism after exercise in mice]. (PubMedID: 22493896) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Reactivity to substance P of isolated lymphatics in hemorrhagic shock rat]. (PubMedID: 22493897) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Effects of aerobic exercise training on the changes of endothelium-dependent relaxations in rat thoracic aorta rings and its mechanisms]. (PubMedID: 22493898) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Effects of alpha-linolenic acid on inflammation and oxidative stress in the diabetic rats]. (PubMedID: 22493899) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Effect of irbesartan on the proliferation, apoptosis and VEGF mRNA expression of human umbilical vein cell line ea. hy926 in vitro]. (PubMedID: 22493900) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[The change of immunoreactivity in glia cells and its sense by using early Parkinson's disease rat model]. (PubMedID: 22493901) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Role of endotoxin translocation on mesenteric lymph reperfusion aggravating multiple organ injury in SMAO shock rats]. (PubMedID: 22493902) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Role of P38-MAPK signal transduction pathway and effect of panax notoginoside in rats with hypoxic hypercapnia pulmonary hypertension]. (PubMedID: 22493903) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[Zinc supplementation effects on alcoholic liver disease and the molecular mechanism]. (PubMedID: 22493904) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
[The metabolism characteristics of blood lipids and the correlation analysis of blood lipids and related factors such as age in the middle-aged and elderly men]. (PubMedID: 22493905) Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
01/01/2012
Human rights from the grassroots up: Vermont's campaign for universal health care. (PubMedID: 22773094) Health and human rights
01/01/2012
Bridging international law and rights-based litigation: mapping health-related rights through the development of the Global Health and Human Rights Database. (PubMedID: 22773095) Health and human rights
01/01/2012
Between the court and the clinic: lawsuits for medicines and the right to health in Brazil. (PubMedID: 22773096) Health and human rights
01/01/2012
Pillars for progress on the right to health: harnessing the potential of human rights through a Framework Convention on Global Health. (PubMedID: 22773097) Health and human rights
01/01/2012
New Zealand's National Health and Disability Advocacy Service: a successful model of advocacy. (PubMedID: 22773098) Health and human rights
01/01/2012
Brazilian policy responses to violence against women: government strategy and the help-seeking behaviors of women who experience violence. (PubMedID: 22773099) Health and human rights
01/01/2012
Child rights, right to water and sanitation, and human security. (PubMedID: 22773100) Health and human rights
01/01/2012
Filling the gap: a learning network for health an human rights in the Western Cape, South Africa. (PubMedID: 22773101) Health and human rights
01/01/2012
Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. (PubMedID: 22138231) Trends in cognitive sciences
01/01/2012
Stigma as a barrier to recovery from mental illness. (PubMedID: 22153582) Trends in cognitive sciences
01/01/2012
What is neuropsychoanalysis? Clinically relevant studies of the minded brain. (PubMedID: 22153583) Trends in cognitive sciences
01/01/2012
A neurocomputational approach to obsessive-compulsive disorder. (PubMedID: 22154352) Trends in cognitive sciences
01/01/2012
Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. (PubMedID: 22155014) Trends in cognitive sciences
01/01/2012
Large-scale brain systems in ADHD: beyond the prefrontal-striatal model. (PubMedID: 22169776) Trends in cognitive sciences
01/01/2012
Cognition in schizophrenia: core psychological and neural mechanisms. (PubMedID: 22169777) Trends in cognitive sciences
01/01/2012
The disordered mind. (PubMedID: 22169778) Trends in cognitive sciences
01/01/2012
The psychopath magnetized: insights from brain imaging. (PubMedID: 22177031) Trends in cognitive sciences
01/01/2012
Computational psychiatry. (PubMedID: 22177032) Trends in cognitive sciences
01/01/2012
From small to big molecules: how do we prevent and delay the progression of age-related neurodegeneration? (PubMedID: 22211681) Current pharmaceutical design
01/01/2012
Immunopathogenesis of neurodegenerative diseases: current therapeutic models of neuroprotection with special reference to natural products. (PubMedID: 22211682) Current pharmaceutical design
01/01/2012
High fat meal increase of IL-17 is prevented by ingestion of fruit juice drink in healthy overweight subjects. (PubMedID: 22211683) Current pharmaceutical design
01/01/2012
Nutraceuticals and prevention of neurodegeneration. (PubMedID: 22211684) Current pharmaceutical design
01/01/2012
Protective effects of chronic green tea consumption on age-related neurodegeneration. (PubMedID: 22211685) Current pharmaceutical design
01/01/2012
Resveratrol, a neuroprotective supplement for Alzheimer's disease. (PubMedID: 22211686) Current pharmaceutical design
01/01/2012
Fermented grape marc (FGM): immunomodulating properties and its potential exploitation in the treatment of neurodegenerative diseases. (PubMedID: 22211687) Current pharmaceutical design
01/01/2012
Neuroprotective effects of lutein in the retina. (PubMedID: 22211688) Current pharmaceutical design
01/01/2012
Nutraceuticals and Prevention of Neurodegeneration Herbal Medicines for the Prevention and Treatment of Alzheimer's Disease. (PubMedID: 22211689) Current pharmaceutical design
01/01/2012
Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits a-synuclein oligomer formation: relevance to Parkinson's disease. (PubMedID: 22211690) Current pharmaceutical design
01/01/2012
Curcumin: a potential neuroprotective agent in Parkinson's disease. (PubMedID: 22211691) Current pharmaceutical design
01/01/2012
The ovary feels fine when paracrine and autocrine networks cooperate with gonadotropins in the regulation of folliculogenesis. (PubMedID: 22229553) Current pharmaceutical design
01/01/2012
Extrapituitary actions of GnRH antagonists: prospects for in vitro fertilization programs. (PubMedID: 22229554) Current pharmaceutical design
01/01/2012
Biomolecules of human female fertility--potential therapeutic targets for pharmaceutical design. (PubMedID: 22229555) Current pharmaceutical design
01/01/2012
Identification and validation of hits from high throughput screens for CFTR modulators. (PubMedID: 22229556) Current pharmaceutical design
01/01/2012
Early in vivo testing to assess new therapeutic interventions in CF patients. (PubMedID: 22229557) Current pharmaceutical design
01/01/2012
Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors. (PubMedID: 22229558) Current pharmaceutical design
01/01/2012
Probing heterotrimeric G protein activation: applications to biased ligands. (PubMedID: 22229559) Current pharmaceutical design
01/01/2012
Enkephalin degrading enzymes: metalloproteases with high potential for drug development. (PubMedID: 22229560) Current pharmaceutical design
01/01/2012
Editorial [ hot topic: new frontiers in female reproduction and fertility (executive guest editor: sandra cecconi)]. (PubMedID: 22229561) Current pharmaceutical design
01/01/2012
The control of cell cycle in mouse primordial germ cells: old and new players. (PubMedID: 22229562) Current pharmaceutical design
01/01/2012
Unveiling mRNA changes during meiotic progression and pre-implantation development: help from large animal models. (PubMedID: 22229563) Current pharmaceutical design
01/01/2012
Phenotypes and enviromental factors: their influence in PCOS. (PubMedID: 22229564) Current pharmaceutical design
01/01/2012
Stem cells in adult human ovaries: from female fertility to ovarian cancer. (PubMedID: 22229565) Current pharmaceutical design
01/01/2012
Fertility preservation in women after the cancer. (PubMedID: 22229566) Current pharmaceutical design
01/01/2012
Angiogenesis and microvasculature in the female reproductive organs: physiological and pathological implications. (PubMedID: 22229567) Current pharmaceutical design
01/01/2012
Application of RNA interference for the control of female reproductive functions. (PubMedID: 22229568) Current pharmaceutical design
01/01/2012
New developments in pharmaceutical treatments for cystic fibrosis. (PubMedID: 22229569) Current pharmaceutical design
01/01/2012
New therapies in cystic fibrosis. (PubMedID: 22229570) Current pharmaceutical design
01/01/2012
Progress in gene and cell therapy for cystic fibrosis lung disease. (PubMedID: 22229571) Current pharmaceutical design
01/01/2012
Modifier gene studies to identify new therapeutic targets in cystic fibrosis. (PubMedID: 22229572) Current pharmaceutical design
01/01/2012
New developments in inhaled antibiotics for the treatment of Pseudomonas aeruginosa. (PubMedID: 22229573) Current pharmaceutical design
01/01/2012
New treatments for emerging cystic fibrosis pathogens other than Pseudomonas. (PubMedID: 22229574) Current pharmaceutical design
01/01/2012
Nitric oxide and L-arginine deficiency in cystic fibrosis. (PubMedID: 22229575) Current pharmaceutical design
01/01/2012
The multiple layers of signaling selectivity at protease-activated receptors. (PubMedID: 22229576) Current pharmaceutical design
01/01/2012
The G-protein coupled receptor family: actors with many faces. (PubMedID: 22229577) Current pharmaceutical design
01/01/2012
GRK2 inhibition in heart failure: something old, something new. (PubMedID: 22229578) Current pharmaceutical design
01/01/2012
The plasticity of the 7TMR signaling machinery and the search for pharmacological selectivity. (PubMedID: 22229579) Current pharmaceutical design
01/01/2012
GRK2 at the control shaft of cellular metabolism. (PubMedID: 22229580) Current pharmaceutical design
01/01/2012
Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson's disease. (PubMedID: 22229581) Current pharmaceutical design
01/01/2012
Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects. (PubMedID: 22229582) Current pharmaceutical design
01/01/2012
Anti-inflammatory effects of anti-platelet treatment in atherosclerosis. (PubMedID: 22236116) Current pharmaceutical design
01/01/2012
"Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. (PubMedID: 22236117) Current pharmaceutical design
01/01/2012
Recent progress in small molecule CCR5 antagonists as potential HIV-1 entry inhibitors. (PubMedID: 22236118) Current pharmaceutical design
01/01/2012
Editorial: Peptides in diagnosis and therapy. (PubMedID: 22236119) Current pharmaceutical design
01/01/2012
Mining PeptideAtlas for biomarkers and therapeutics in human disease. (PubMedID: 22236120) Current pharmaceutical design
01/01/2012
Peptides for therapy and diagnosis of Alzheimer's disease. (PubMedID: 22236121) Current pharmaceutical design
01/01/2012
Ghrelin and the brain-gut axis as a pharmacological target for appetite control. (PubMedID: 22236122) Current pharmaceutical design
01/01/2012
Short peptide modules for enhancing intestinal barrier function. (PubMedID: 22236123) Current pharmaceutical design
01/01/2012
Peptides in oral diseases. (PubMedID: 22236124) Current pharmaceutical design
01/01/2012
Apelin in the control of body fluid homeostasis and cardiovascular functions. (PubMedID: 22236125) Current pharmaceutical design
01/01/2012
Thymosin ß4 protein therapy for cardiac repair. (PubMedID: 22236126) Current pharmaceutical design
01/01/2012
Therapeutic potential of host defense peptides in antibiotic-resistant infections. (PubMedID: 22236127) Current pharmaceutical design
01/01/2012
Peptides in melanoma therapy. (PubMedID: 22236128) Current pharmaceutical design
01/01/2012
Circumscribing the conformational peptide epitope landscape. (PubMedID: 22236129) Current pharmaceutical design
01/01/2012
The vulnerability to schizophrenia mainstream research paradigms and phenomenological directions. (PubMedID: 22239564) Current pharmaceutical design
01/01/2012
The ultra high risk approach to define psychosis risk. (PubMedID: 22239565) Current pharmaceutical design
01/01/2012
Basic symptoms and the prediction of first-episode psychosis. (PubMedID: 22239566) Current pharmaceutical design
01/01/2012
Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. (PubMedID: 22239567) Current pharmaceutical design
01/01/2012
Can we detect psychotic-like experiences in the general population? (PubMedID: 22239568) Current pharmaceutical design
01/01/2012
Reliability and validity of the Comprehensive Assessment of the At Risk Mental State, Italian version (CAARMS-I). (PubMedID: 22239569) Current pharmaceutical design
01/01/2012
Abnormal bodily experiences may be a marker of early schizophrenia? (PubMedID: 22239570) Current pharmaceutical design
01/01/2012
Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. (PubMedID: 22239571) Current pharmaceutical design
01/01/2012
Neuroimaging and resilience factors--staging of the at-risk mental state? (PubMedID: 22239572) Current pharmaceutical design
01/01/2012
The relationship of developmental changes in white matter to the onset of psychosis. (PubMedID: 22239573) Current pharmaceutical design
01/01/2012
Relationship between gyrification and functional connectivity of the prefrontal cortex in subjects at high genetic risk of schizophrenia. (PubMedID: 22239574) Current pharmaceutical design
01/01/2012
Episodic memory dysfunction in individuals at high-risk of psychosis: a systematic review of neuropsychological and neurofunctional studies. (PubMedID: 22239575) Current pharmaceutical design
01/01/2012
From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments. (PubMedID: 22239576) Current pharmaceutical design
01/01/2012
Glutamate and psychosis risk. (PubMedID: 22239577) Current pharmaceutical design
01/01/2012
Neurophysiological alterations in the prepsychotic phases. (PubMedID: 22239578) Current pharmaceutical design
01/01/2012
Rapid detection by multiplex PCR of Genomic Islands, prophages and Integrative Conjugative Elements in V. cholerae 7th pandemic variants. (PubMedID: 22062086) Journal of microbiological methods
01/01/2012
A polyphasic approach for the characterization of endophytic Alternaria strains isolated from grapevines. (PubMedID: 22123507) Journal of microbiological methods
01/01/2012
Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis. (PubMedID: 22133919) Journal of microbiological methods
01/01/2012
Multiplex PCR and a chromogenic DNA macroarray for the detection of Listeria monocytogens, Staphylococcus aureus, Streptococcus agalactiae, Enterobacter sakazakii, Escherichia coli O157:H7, Vibrio parahaemolyticus, Salmonella spp. and Pseudomonas fluorescens in milk and meat samples. (PubMedID: 22101309) Journal of microbiological methods
01/01/2012
High-throughput analysis of growth differences among phage strains. (PubMedID: 22101310) Journal of microbiological methods
01/01/2012
Towards a rapid molecular diagnostic for melioidosis: Comparison of DNA extraction methods from clinical specimens. (PubMedID: 22108495) Journal of microbiological methods
01/01/2012
Hollow-fiber ultrafiltration for simultaneous recovery of viruses, bacteria and parasites from reclaimed water. (PubMedID: 22108496) Journal of microbiological methods
01/01/2012
Rapid detection of blaIMP-6 by amplification refractory mutation system. (PubMedID: 22108497) Journal of microbiological methods
01/01/2012
Multiplex allele-specific PCR combined with PCR-RFLP analysis for rapid detection of gyrA gene fluoroquinolone resistance mutations in Mycobacterium tuberculosis. (PubMedID: 22115861) Journal of microbiological methods
01/01/2012
Rapid and high resolution genotyping of all Escherichia coli serotypes using 10 genomic repeat-containing loci. (PubMedID: 22088357) Journal of microbiological methods
01/01/2012
Inactivation of Alternaria brassicicola spores by supercritical carbon dioxide with ethanol entrainer. (PubMedID: 22088358) Journal of microbiological methods
01/01/2012
Natural biopolymer for preservation of microorganisms during sampling and storage. (PubMedID: 22093998) Journal of microbiological methods
01/01/2012
Molecular serogrouping of porcine enterotoxigenic Escherichia coli from Australia. (PubMedID: 22093999) Journal of microbiological methods
01/01/2012
A critical assessment of the occurrence and extend of oxygen contamination during anaerobic incubations utilizing commercially available vials. (PubMedID: 22101311) Journal of microbiological methods
01/01/2012
Multilocus sequence typing of Salmonella strains by high-throughput sequencing of selectively amplified target genes. (PubMedID: 22108494) Journal of microbiological methods
01/01/2012
Efficient transposition of IS204-derived plasmids in Streptomyces coelicolor. (PubMedID: 22079690) Journal of microbiological methods
01/01/2012
PhyloChip™ microarray comparison of sampling methods used for coral microbial ecology. (PubMedID: 22085912) Journal of microbiological methods
01/01/2012
A high-throughput screen to identify novel calcineurin inhibitors. (PubMedID: 22056231) Journal of microbiological methods
01/01/2012
Production and characterization of a novel monoclonal antibody against Vibrio parahaemolyticus F0F1 ATP synthase's delta subunit and its application for rapid identification of the pathogen. (PubMedID: 22056232) Journal of microbiological methods
01/01/2012
Nonlinear electrophoresis for purification of soil DNA for metagenomics. (PubMedID: 22056233) Journal of microbiological methods
01/01/2012
Novel broad-host-range vehicles for cloning and shuffling of gene cassettes. (PubMedID: 22056795) Journal of microbiological methods
01/01/2012
MALDI-typing of infectious algae of the genus Prototheca using SOM portraits. (PubMedID: 22062088) Journal of microbiological methods
01/01/2012
Relative diversity and community structure analysis of rumen protozoa according to T-RFLP and microscopic methods. (PubMedID: 22033497) Journal of microbiological methods
01/01/2012
High resolution melting PCR to differentiate Mycobacterium avium subsp. paratuberculosis"cattle type" and "sheep type". (PubMedID: 22033498) Journal of microbiological methods
01/01/2012
LC-MS method for screening unknown microbial carotenoids and isoprenoid quinones. (PubMedID: 22036764) Journal of microbiological methods
01/01/2012
Methods to produce and safely work with large numbers of Toxoplasma gondii oocysts and bradyzoite cysts. (PubMedID: 22037023) Journal of microbiological methods
01/01/2012
Epifluorescence and atomic force microscopy: Two innovative applications for studying phage-host interactions in Lactobacillus helveticus. (PubMedID: 22024504) Journal of microbiological methods
01/01/2012
A rapid multiplex DNA suspension array method for Salmonella typhimurium subtyping using prophage-related markers. (PubMedID: 22015815) Journal of microbiological methods
01/01/2012
Determining a minimum detection threshold in terminal restriction fragment length polymorphism analysis. (PubMedID: 22015816) Journal of microbiological methods
01/01/2012
Spontaneous bacteriocin resistance in Listeria monocytogenes as a susceptibility screen for identifying different mechanisms of resistance and modes of action by bacteriocins of lactic acid bacteria. (PubMedID: 22001443) Journal of microbiological methods
01/01/2012
Developing treatments for impaired cognition in schizophrenia. (PubMedID: 22178120) Trends in cognitive sciences
01/01/2012
Neural circuits underlying the pathophysiology of mood disorders. (PubMedID: 22197477) Trends in cognitive sciences
01/01/2012
Interview with Steven E. Hyman. (PubMedID: 22329001) Trends in cognitive sciences
01/01/2012
HOXC9: a key regulator of endothelial cell quiescence and vascular morphogenesis. (PubMedID: 22841837) Trends in cardiovascular medicine
01/01/2012
On mechanosensation, acto/myosin interaction, and hypertrophy. (PubMedID: 22841838) Trends in cardiovascular medicine
01/01/2012
Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention. (PubMedID: 22841840) Trends in cardiovascular medicine
01/01/2012
Translational findings from cardiovascular stem cell research. (PubMedID: 22940024) Trends in cardiovascular medicine
01/01/2012
Role of neuronal calcium sensor-1 in the cardiovascular system. (PubMedID: 22940025) Trends in cardiovascular medicine
01/01/2012
Burden of osteoporosis in adults in Korea: a national health insurance database study. (PubMedID: 21633927) Journal of bone and mineral metabolism
01/01/2012
Novel heterozygous tissue-nonspecific alkaline phosphatase (TNAP) gene mutations causing lethal perinatal hypophosphatasia. (PubMedID: 21638016) Journal of bone and mineral metabolism
01/01/2012
The differential relationship between fat mass and bone mineral density by gender and menopausal status. (PubMedID: 21644057) Journal of bone and mineral metabolism
01/01/2012
Osteoporosis onset differences between rural and metropolitan populations: correlation to fracture type, severity, and treatment efficacy. (PubMedID: 21667356) Journal of bone and mineral metabolism
01/01/2012
The identification of novel mutations in COL1A1, COL1A2, and LEPRE1 genes in Chinese patients with osteogenesis imperfecta. (PubMedID: 21667357) Journal of bone and mineral metabolism
01/01/2012
Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials. (PubMedID: 21674202) Journal of bone and mineral metabolism
01/01/2012
FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation. (PubMedID: 21678127) Journal of bone and mineral metabolism
01/01/2012
Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy. (PubMedID: 21710176) Journal of bone and mineral metabolism
01/01/2012
FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets. (PubMedID: 21710177) Journal of bone and mineral metabolism
01/01/2012
The role of lean body mass and physical activity in bone health in children. (PubMedID: 21732232) Journal of bone and mineral metabolism
01/01/2012
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia. (PubMedID: 21739089) Journal of bone and mineral metabolism
01/01/2012
Elbow loading promotes longitudinal bone growth of the ulna and the humerus. (PubMedID: 21748461) Journal of bone and mineral metabolism
01/01/2012
Low-magnitude whole body vibration does not affect bone mass but does affect weight in ovariectomized rats. (PubMedID: 21773704) Journal of bone and mineral metabolism
01/01/2012
Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitro. (PubMedID: 21993629) Journal of bone and mineral metabolism
01/01/2012
The expanding family of hypophosphatemic syndromes. (PubMedID: 22167381) Journal of bone and mineral metabolism
01/01/2012
Can features of phosphate toxicity appear in normophosphatemia? (PubMedID: 22219005) Journal of bone and mineral metabolism
01/01/2012
Registration of clinical trials--a regional perspective. (PubMedID: 22360004) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Knowledge, attitudes and practices about leishmaniasis among cutaneous leishmaniasis patients in Aleppo, Syrian Arab Republic. (PubMedID: 22360005) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Factors associated with the spread of dengue fever in Jeddah Governorate, Saudi Arabia. (PubMedID: 22360006) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
A distinct autosomal recessive ocular anomaly in Chaharborj, Islamic Republic of Iran. (PubMedID: 22360007) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Early outcomes of pandemic influenza (H1N1) 2009 surveillance in Abu Dhabi Emirate, May-August 2009. (PubMedID: 22360008) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Isolation and screening of methicillin-resistant Staphylococcus aureus from health care workers in Libyan hospitals. (PubMedID: 22360009) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Pediculosis capitis among primary-school children in Mafraq Governorate, Jordan. (PubMedID: 22360010) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Survey of skin disorders in newborns: clinical observation in an Egyptian medical centre nursery. (PubMedID: 22360011) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
[Reasons for using emergency departments of major hospitals in Greater Tunis]. (PubMedID: 22360012) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Sensitivity and specificity of ultrasound in the diagnosis of acute appendicitis. (PubMedID: 22360013) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Management of the use of public health pesticides in the face of the increasing burden of vector-borne diseases in the Eastern Mediterranean region. (PubMedID: 22360014) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Efficacy of constitutional support to enhance access to essential medicines as a human right to health in the Eastern Mediterranean region. (PubMedID: 22360015) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
[Pharmacoepidemiolgy: regulatory basis, methodological approaches and scope]. (PubMedID: 22360016) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Birthing in the Arab region: translating research into practice. (PubMedID: 22360017) Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit
01/01/2012
Regulation of metabolism: the circadian clock dictates the time. (PubMedID: 22169754) Trends in Endocrinology and Metabolism
01/01/2012
Channeling dysglycemia: ion-channel variations perturbing glucose homeostasis. (PubMedID: 22134088) Trends in Endocrinology and Metabolism
01/01/2012
ECM roles in the function of metabolic tissues. (PubMedID: 22070921) Trends in Endocrinology and Metabolism
01/01/2012
Sex hormone-binding globulin and type 2 diabetes mellitus. (PubMedID: 22047952) Trends in Endocrinology and Metabolism
01/01/2012
Galectins: guardians of eutherian pregnancy at the maternal-fetal interface. (PubMedID: 22036528) Trends in Endocrinology and Metabolism
01/01/2012
Leptin action in pubertal development: recent advances and unanswered questions. (PubMedID: 21978495) Trends in Endocrinology and Metabolism
01/01/2012
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. (PubMedID: 22239579) Current pharmaceutical design
01/01/2012
Cingulate volume abnormalities in emerging psychosis. (PubMedID: 22239580) Current pharmaceutical design
01/01/2012
Biochemical markers of impending psychosis. (PubMedID: 22239581) Current pharmaceutical design
01/01/2012
Genetic vulnerability to psychosis and cortical function: epistatic effects between DAAO and G72. (PubMedID: 22239582) Current pharmaceutical design
01/01/2012
Immigration, social environment and onset of psychotic disorders. (PubMedID: 22239583) Current pharmaceutical design
01/01/2012
Stress and the prodromal phase of psychosis. (PubMedID: 22239584) Current pharmaceutical design
01/01/2012
Cognitive remediation in the early course of schizophrenia: a critical review. (PubMedID: 22239585) Current pharmaceutical design
01/01/2012
Cannabis abuse and vulnerability to psychosis: targeting preventive services. (PubMedID: 22239586) Current pharmaceutical design
01/01/2012
Pharmacological prevention and treatment in clinical at-risk states for psychosis. (PubMedID: 22239587) Current pharmaceutical design
01/01/2012
Cognitive behavioral therapy in prodromal psychosis. (PubMedID: 22239588) Current pharmaceutical design
01/01/2012
Psychoeducation in subjects at elevated risk for psychosis--a critical review. (PubMedID: 22239589) Current pharmaceutical design
01/01/2012
Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study. (PubMedID: 22239590) Current pharmaceutical design
01/01/2012
Polyunsaturated fatty acids in emerging psychosis. (PubMedID: 22239591) Current pharmaceutical design
01/01/2012
Economic impact of early detection and early intervention of psychosis. (PubMedID: 22239592) Current pharmaceutical design
01/01/2012
Philosophical issues in the prodromal phase of psychosis. (PubMedID: 22239593) Current pharmaceutical design
01/01/2012
Ethical implications for clinical practice and future research in "at risk" individuals. (PubMedID: 22239594) Current pharmaceutical design
01/01/2012
Editorial: From structural plasticity to functional diversity of 7TMRs: biased agonism and beyond. (PubMedID: 22250770) Current pharmaceutical design
01/01/2012
Sympathetic nervous system dysfunction in multiple sclerosis, linking neurodegeneration to a reduced response to therapy. (PubMedID: 22272817) Current pharmaceutical design
01/01/2012
Human serum albumin conjugated biomolecules for cancer molecular imaging. (PubMedID: 22272822) Current pharmaceutical design
01/01/2012
A concise review of current radiopharmaceuticals in tumor angiogenesis imaging. (PubMedID: 22272823) Current pharmaceutical design
01/01/2012
Development of radiolabeled compounds for myocardial perfusion imaging. (PubMedID: 22272824) Current pharmaceutical design
01/01/2012
Folate based radiopharmaceuticals for imaging and therapy of cancer and inflammation. (PubMedID: 22272825) Current pharmaceutical design
01/01/2012
Recent advances on radionuclide labeled hypoxia-imaging agents. (PubMedID: 22272826) Current pharmaceutical design
01/01/2012
Development of specific radiopharmaceuticals for infection imaging by targeting infectious micro-organisms. (PubMedID: 22272827) Current pharmaceutical design
01/01/2012
Recent advance in the development of radiolabeled in vivo probes for diagnosis and therapy. (PubMedID: 22272828) Current pharmaceutical design
01/01/2012
Past, present and future in the treatment of major psychotic disorders. (PubMedID: 22280431) Current pharmaceutical design
01/01/2012
Glutamatergic animal models of schizophrenia. (PubMedID: 22280432) Current pharmaceutical design
01/01/2012
The possible involvement of NMDA glutamate receptor in the etiopathogenesis of bipolar disorder. (PubMedID: 22280433) Current pharmaceutical design
01/01/2012
Is dopamine neurotransmission altered in prodromal schizophrenia? A review of the evidence. (PubMedID: 22280434) Current pharmaceutical design
01/01/2012
Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia. (PubMedID: 22280435) Current pharmaceutical design
01/01/2012
Basic pharmacology of NMDA receptors. (PubMedID: 22280436) Current pharmaceutical design
01/01/2012
In vivo pharmacokinetics, immunogenicity and mechanism of PEGylated antitumor polypeptide. (PubMedID: 22283767) Current pharmaceutical design
01/01/2012
New developments in treatment after lung transplantation. (PubMedID: 22283768) Current pharmaceutical design
01/01/2012
Inhibition of the renin-angiotensin-aldosterone system: how to obtain this. (PubMedID: 22283769) Current pharmaceutical design
01/01/2012
Renin-angiotensin antagonists: therapeutic effects beyond blood pressure control? (PubMedID: 22283770) Current pharmaceutical design
01/01/2012
Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis. (PubMedID: 22283771) Current pharmaceutical design
01/01/2012
Vaccination against high blood pressure. (PubMedID: 22283772) Current pharmaceutical design
01/01/2012
Combinations of renin-angiotensin-aldosterone system antagonists: true advantages? (PubMedID: 22283773) Current pharmaceutical design
01/01/2012
Role of renin-angiotensin system in inflammation, immunity and aging. (PubMedID: 22283774) Current pharmaceutical design
01/01/2012
Renin-angiotensin-aldosterone system antagonists and the prevention of type 2 diabetes mellitus. (PubMedID: 22283775) Current pharmaceutical design
01/01/2012
RAAS inhibition and renal protection. (PubMedID: 22283776) Current pharmaceutical design
01/01/2012
Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. (PubMedID: 22283779) Current pharmaceutical design
01/01/2012
Animal models for neurodegenerative diseases associated to accumulation of misfolded protein aggregates. (PubMedID: 22288399) Current pharmaceutical design
01/01/2012
Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions. (PubMedID: 22288400) Current pharmaceutical design
01/01/2012
The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease. (PubMedID: 22288401) Current pharmaceutical design
01/01/2012
Drosophila models of proteinopathies: the little fly that could. (PubMedID: 22288402) Current pharmaceutical design
01/01/2012
Nonhuman primate models of Alzheimer-like cerebral proteopathy. (PubMedID: 22288403) Current pharmaceutical design
01/01/2012
Natural animal models of neurodegenerative protein misfolding diseases. (PubMedID: 22288404) Current pharmaceutical design
01/01/2012
Sigma-1 receptors: potential targets for the treatment of substance abuse. (PubMedID: 22288407) Current pharmaceutical design
01/01/2012
Pharmacology of sigma (s) receptor ligands from a behavioral perspective. (PubMedID: 22288408) Current pharmaceutical design
01/01/2012
Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases. (PubMedID: 22288409) Current pharmaceutical design
01/01/2012
The therapeutic potential of sigma (s) receptors for the treatment of central nervous system diseases: evaluation of the evidence. (PubMedID: 22288410) Current pharmaceutical design
01/01/2012
Classes of sigma2 (s2) receptor ligands: structure affinity relationship (SAfiR) studies and antiproliferative activity. (PubMedID: 22288411) Current pharmaceutical design
01/01/2012
The ligand binding region of the sigma-1 receptor: studies utilizing photoaffinity probes, sphingosine and N-alkylamines. (PubMedID: 22288412) Current pharmaceutical design
01/01/2012
Pharmacophore models and development of spirocyclic ligands for s1 receptors. (PubMedID: 22288413) Current pharmaceutical design
01/01/2012
Sigma receptor research: progress towards diagnostic and therapeutic uses of sigma ligands. (PubMedID: 22288414) Current pharmaceutical design
01/01/2012
Old wine in a new bottle: the Warburg effect and anticancer mechanisms of resveratrol. (PubMedID: 22288443) Current pharmaceutical design
01/01/2012
Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents. (PubMedID: 22288444) Current pharmaceutical design
01/01/2012
Pharmacological modulation of microparticle release: new strategies for the management of atherothrombotic vascular disorders. (PubMedID: 22288445) Current pharmaceutical design
01/01/2012
Non-systemic drugs: a critical review. (PubMedID: 22300258) Current pharmaceutical design
01/01/2012
Mechanisms of neutrophil-mediated disease: innovative therapeutic interventions. (PubMedID: 22303877) Current pharmaceutical design
01/01/2012
Prodromal psychosis: diagnosis and treatment. (PubMedID: 22309115) Current pharmaceutical design
01/01/2012
In silico lead identification and optimization for drug discovery. (PubMedID: 22316149) Current pharmaceutical design
01/01/2012
Identification of HIV inhibitors guided by free energy perturbation calculations. (PubMedID: 22316150) Current pharmaceutical design
01/01/2012
Computational drug design targeting protein-protein interactions. (PubMedID: 22316151) Current pharmaceutical design
01/01/2012
From laptop to benchtop to bedside: structure-based drug design on protein targets. (PubMedID: 22316152) Current pharmaceutical design
01/01/2012
The challenges involved in modeling toxicity data in silico: a review. (PubMedID: 22316153) Current pharmaceutical design
01/01/2012
Computational prediction of protein hot spot residues. (PubMedID: 22316154) Current pharmaceutical design
01/01/2012
The different ways through which specificity works in orthosteric and allosteric drugs. (PubMedID: 22316155) Current pharmaceutical design
01/01/2012
Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases. (PubMedID: 22316156) Current pharmaceutical design
01/01/2012
Multi-parameter optimization: identifying high quality compounds with a balance of properties. (PubMedID: 22316157) Current pharmaceutical design
01/01/2012
Cis-enone resorcylic acid lactones (RALs) as irreversible protein kinase inhibitors. (PubMedID: 22316158) Current pharmaceutical design
01/01/2012
Herbal medicines for the prevention and treatment of Alzheimer's disease. (PubMedID: 22316321) Current pharmaceutical design
01/01/2012
Stem cell ageing and apoptosis. (PubMedID: 22352749) Current pharmaceutical design
01/01/2012
Clinical applications and biosafety of human adult mesenchymal stem cells. (PubMedID: 22352750) Current pharmaceutical design
01/01/2012
Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. (PubMedID: 22352751) Current pharmaceutical design
01/01/2012
Nuclear PI-PLCß1 and myelodysplastic syndromes: genetics and epigenetics. (PubMedID: 22352752) Current pharmaceutical design
01/01/2012
Role of miRNAs in muscle stem cell biology: proliferation, differentiation and death. (PubMedID: 22352753) Current pharmaceutical design
01/01/2012
The combined use of mesenchymal stromal cells and scaffolds for bone repair. (PubMedID: 22352754) Current pharmaceutical design
01/01/2012
Chromatin modification and senescence. (PubMedID: 22352755) Current pharmaceutical design
01/01/2012
Genesis of ultrasonic microbubbles: a quick historical overview. (PubMedID: 22352767) Current pharmaceutical design
01/01/2012
How do microbubbles and ultrasound interact? Basic physical, dynamic and engineering principles. (PubMedID: 22352768) Current pharmaceutical design
01/01/2012
Methods of preparation of multifunctional microbubbles and their in vitro / in vivo assessment of stability, functional and structural properties. (PubMedID: 22352769) Current pharmaceutical design
01/01/2012
Phase-change contrast agents for imaging and therapy. (PubMedID: 22352770) Current pharmaceutical design
01/01/2012
Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectives. (PubMedID: 22352771) Current pharmaceutical design
01/01/2012
Targeted ultrasound imaging of cancer: an emerging technology on its way to clinics. (PubMedID: 22352772) Current pharmaceutical design
01/01/2012
Contrast echocardiography: an update on clinical applications. (PubMedID: 22352773) Current pharmaceutical design
01/01/2012
Analysis of contrast-enhanced intravascular ultrasound images for the assessment of coronary plaque neoangiogenesis: another step closer to the identification of the vulnerable plaque. (PubMedID: 22352774) Current pharmaceutical design
01/01/2012
Role of contrast-enhanced ultrasound in the follow-up of endo-vascular aortic aneurysm repair: an effective and safe surveillance method. (PubMedID: 22352775) Current pharmaceutical design
01/01/2012
Why and how do microbubbles enhance the effectiveness of diagnostic and therapeutic interventions in cerebrovascular disease? (PubMedID: 22352776) Current pharmaceutical design
01/01/2012
Contrast-enhanced ultrasound for liver imaging: recent advances. (PubMedID: 22352777) Current pharmaceutical design
01/01/2012
Editorial: Bioengineering and clinical perspectives in diagnostic and therapeutic applications of microbubbles. (PubMedID: 22352778) Current pharmaceutical design
01/01/2012
A critical appraisal of the functional evolution of P2Y12 antagonists as antiplatelet drugs. (PubMedID: 22360514) Current pharmaceutical design
01/01/2012
Proton dynamics in cancer. (PubMedID: 22360551) Current pharmaceutical design
01/01/2012
NHE-1: a promising target for novel anti-cancer therapeutics. (PubMedID: 22360552) Current pharmaceutical design
01/01/2012
A rationale for the use of proton pump inhibitors as antineoplastic agents. (PubMedID: 22360553) Current pharmaceutical design
01/01/2012
Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer. (PubMedID: 22360554) Current pharmaceutical design
01/01/2012
Translational research of photodynamic therapy with acridine orange which targets cancer acidity. (PubMedID: 22360555) Current pharmaceutical design
01/01/2012
Resveratrol in cancer: cellular and mitochondrial consequences of proton transport inhibition. (PubMedID: 22360556) Current pharmaceutical design
01/01/2012
Physiology, pharmacology and pathophysiology of the pH regulatory transport proteins NHE1 and NBCn1: similarities, differences, and implications for cancer therapy. (PubMedID: 22360557) Current pharmaceutical design
01/01/2012
Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. (PubMedID: 22360558) Current pharmaceutical design
01/01/2012
Inhibition of V-ATPase and carbonic anhydrases as interference strategy with tumor acidification processes. (PubMedID: 22360559) Current pharmaceutical design
01/01/2012
Acid-extrusion from tissue: the interplay between membrane transporters and pH buffers. (PubMedID: 22360560) Current pharmaceutical design
01/01/2012
Rheumatoid arthritis: cardiovascular manifestations, pathogenesis, and therapy. (PubMedID: 22364129) Current pharmaceutical design
01/01/2012
Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets. (PubMedID: 22364130) Current pharmaceutical design
01/01/2012
Excess cardiovascular risk in inflammatory rheumatic diseases: pathophysiology and targeted therapy. (PubMedID: 22364131) Current pharmaceutical design
01/01/2012
Inflammation-induced thrombosis: mechanisms, disease associations and management. (PubMedID: 22364132) Current pharmaceutical design
01/01/2012
Inflammation and vascular responses to acute mental stress: implications for the triggering of myocardial infarction. (PubMedID: 22364133) Current pharmaceutical design
01/01/2012
The effects of tumor necrosis factor inhibitors on cardiovascular risk in rheumatoid arthritis. (PubMedID: 22364134) Current pharmaceutical design
01/01/2012
The effect of anti-B-cell therapy on the development of atherosclerosis in patients with rheumatoid arthritis. (PubMedID: 22364135) Current pharmaceutical design
01/01/2012
Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials. (PubMedID: 22364136) Current pharmaceutical design
01/01/2012
Marine n-3 fatty acids for cardiovascular risk reduction and disease control in rheumatoid arthritis: "kill two birds with one stone"? (PubMedID: 22364137) Current pharmaceutical design
01/01/2012
Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. (PubMedID: 22364138) Current pharmaceutical design
01/01/2012
Cardiovascular risk and inflammation: pathophysiological mechanisms, drug design, and targets. (PubMedID: 22364139) Current pharmaceutical design
01/01/2012
In vivo and in vitro evaluation of the therapeutic potential of some Turkish Scorzonera species as wound healing agent. (PubMedID: 22369659) Current pharmaceutical design
01/01/2012
Targeted therapies for pancreatic cancer. (PubMedID: 22372496) Current pharmaceutical design
01/01/2012
Novel therapeutic approaches in pancreatic cancer based on genomic alterations. (PubMedID: 22372497) Current pharmaceutical design
01/01/2012
Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system. (PubMedID: 22372498) Current pharmaceutical design
01/01/2012
Mucin-based targeted pancreatic cancer therapy. (PubMedID: 22372499) Current pharmaceutical design
01/01/2012
Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer. (PubMedID: 22372500) Current pharmaceutical design
01/01/2012
Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment. (PubMedID: 22372501) Current pharmaceutical design
01/01/2012
Advances in biomarker research for pancreatic cancer. (PubMedID: 22372502) Current pharmaceutical design
01/01/2012
Sp/KLF family and tumor angiogenesis in pancreatic cancer. (PubMedID: 22372503) Current pharmaceutical design
01/01/2012
Role of Wnt/ß-catenin signaling in drug resistance of pancreatic cancer. (PubMedID: 22372504) Current pharmaceutical design
01/01/2012
Cytokine network: new targeted therapy for pancreatic cancer. (PubMedID: 22372505) Current pharmaceutical design
01/01/2012
State-of-the-art methodologies for the discovery and characterization of DNA G-quadruplex binders. (PubMedID: 22376104) Current pharmaceutical design
01/01/2012
Recent developments in the chemistry and biology of G-quadruplexes with reference to the DNA groove binders. (PubMedID: 22376105) Current pharmaceutical design
01/01/2012
Structure conversion and structure separation of G-quadruplexes investigated by carbazole derivatives. (PubMedID: 22376106) Current pharmaceutical design
01/01/2012
Thrombin binding aptamer, more than a simple aptamer: chemically modified derivatives and biomedical applications. (PubMedID: 22376107) Current pharmaceutical design
01/01/2012
Experimental methods for studying the interactions between G-quadruplex structures and ligands. (PubMedID: 22376108) Current pharmaceutical design
01/01/2012
Cell cycle regulation of G-quadruplex DNA structures at telomeres. (PubMedID: 22376109) Current pharmaceutical design
01/01/2012
Luminescent G-quadruplex probes. (PubMedID: 22376110) Current pharmaceutical design
01/01/2012
RNA G-quadruplexes: G-quadruplexes with "U" turns. (PubMedID: 22376111) Current pharmaceutical design
01/01/2012
Targeting DNA G-quadruplex structures with peptide nucleic acids. (PubMedID: 22376112) Current pharmaceutical design
01/01/2012
G-quadruplex binding ligands: from naturally occurring to rationally designed molecules. (PubMedID: 22376113) Current pharmaceutical design
01/01/2012
Folding versus charge: understanding selective target recognition by the thrombin aptamers. (PubMedID: 22376114) Current pharmaceutical design
01/01/2012
The polymorphisms of DNA G-quadruplex investigated by docking experiments with telomestatin enantiomers. (PubMedID: 22376115) Current pharmaceutical design
01/01/2012
Searching drug-like anti-cancer compound(s) based on G-quadruplex ligands. (PubMedID: 22376116) Current pharmaceutical design
01/01/2012
G-quadruplex DNA aptamers and their ligands: structure, function and application. (PubMedID: 22376117) Current pharmaceutical design
01/01/2012
Screening of a chemical library by HT-G4-FID for discovery of selective G-quadruplex binders. (PubMedID: 22376118) Current pharmaceutical design
01/01/2012
Human telomere RNA: a potential target for ligand recognition. (PubMedID: 22376119) Current pharmaceutical design
01/01/2012
The role of obesity in the development of polycystic ovary syndrome. (PubMedID: 22376149) Current pharmaceutical design
01/01/2012
G-quadruplex based probes for visual detection and sensing. (PubMedID: 22380516) Current pharmaceutical design
01/01/2012
G-quadruplex as signal transducer for biorecognition events. (PubMedID: 22380517) Current pharmaceutical design
01/01/2012
Heterocyclic dications as a new class of telomeric G-quadruplex targeting agents. (PubMedID: 22380518) Current pharmaceutical design
01/01/2012
Inflammation in ischemic stroke subtypes. (PubMedID: 22390641) Current pharmaceutical design
01/01/2012
Effects of physical exercise on inflammatory markers of atherosclerosis. (PubMedID: 22390642) Current pharmaceutical design
01/01/2012
Atherosclerosis as an inflammatory disease. (PubMedID: 22390643) Current pharmaceutical design
01/01/2012
Inflammation in peripheral arterial disease (PAD). (PubMedID: 22390644) Current pharmaceutical design
01/01/2012
Inflammation in coronary artery disease and acute myocardial infarction - is the stage set for novel therapies? (PubMedID: 22390645) Current pharmaceutical design
01/01/2012
Acute coronary syndromes as auto-inflammatory disorders. (PubMedID: 22390646) Current pharmaceutical design
01/01/2012
Editorial: modulation and new mediators in inflammation. (PubMedID: 22390689) Current pharmaceutical design
01/01/2012
Mast cells in allergic and inflammatory diseases. (PubMedID: 22390690) Current pharmaceutical design
01/01/2012
Immunobiology of antigen-specific immunoglobulin free light chains in chronic inflammatory diseases. (PubMedID: 22390691) Current pharmaceutical design
01/01/2012
The nervous system as a critical regulator of immune responses underlying allergy. (PubMedID: 22390692) Current pharmaceutical design
01/01/2012
The mechanism of adjuvanticity of aluminium-containing formulas. (PubMedID: 22390693) Current pharmaceutical design
01/01/2012
The pollen enigma: modulation of the allergic immune response by non-allergenic, pollen-derived compounds. (PubMedID: 22390694) Current pharmaceutical design
01/01/2012
Inflammasome signaling in pathogenesis of lung diseases. (PubMedID: 22390695) Current pharmaceutical design
01/01/2012
Dendritic cells in pathogenesis of COPD. (PubMedID: 22390696) Current pharmaceutical design
01/01/2012
Local inflammation in chronic upper airway disease. (PubMedID: 22390697) Current pharmaceutical design
01/01/2012
Interleukin-7: a key mediator in T cell-driven autoimmunity, inflammation, and tissue destruction. (PubMedID: 22390698) Current pharmaceutical design
01/01/2012
Immune cell-derived vesicles: modulators and mediators of inflammation. (PubMedID: 22390699) Current pharmaceutical design
01/01/2012
Difficulties in describing allergic disease modulation by pre-, pro- and synbiotics. (PubMedID: 22390700) Current pharmaceutical design
01/01/2012
Long chain N-3 polyunsaturated fatty acids in the prevention of allergic and cardiovascular disease. (PubMedID: 22390701) Current pharmaceutical design
01/01/2012
Targeting molecular pathways in human malignancy: current status and future development. (PubMedID: 22390754) Current pharmaceutical design
01/01/2012
Targeting the EGFR-family for therapy: biological challenges and clinical perspective. (PubMedID: 22390755) Current pharmaceutical design
01/01/2012
Anti-VEGF strategies - from antibodies to tyrosine kinase inhibitors: background and clinical development in human cancer. (PubMedID: 22390756) Current pharmaceutical design
01/01/2012
Moving beyond VEGF for anti-angiogenesis strategies in gynecologic cancer. (PubMedID: 22390757) Current pharmaceutical design
01/01/2012
Novel VEGF-independent strategies targeting tumor vasculature: clinical aspects. (PubMedID: 22390758) Current pharmaceutical design
01/01/2012
The endothelin axis as therapeutic target in human malignancies: present and future. (PubMedID: 22390759) Current pharmaceutical design
01/01/2012
Estrogen receptor beta in cancer: an attractive target for therapy. (PubMedID: 22390760) Current pharmaceutical design
01/01/2012
The role of FLT3 kinase as an AML therapy target. (PubMedID: 22390761) Current pharmaceutical design
01/01/2012
Tubulins as therapeutic targets in cancer: from bench to bedside. (PubMedID: 22390762) Current pharmaceutical design
01/01/2012
Novel drugs targeting microtubules: the role of epothilones. (PubMedID: 22390763) Current pharmaceutical design
01/01/2012
Approaches for developing novel microtubule targeting agents (MTAs) for therapeutic exploitation. (PubMedID: 22390764) Current pharmaceutical design
01/01/2012
Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations. (PubMedID: 22390765) Current pharmaceutical design
01/01/2012
Chemoradiotherapy of human tumors: novel approaches from nanomedicine. (PubMedID: 22390766) Current pharmaceutical design
01/01/2012
Cancer stem cells and novel targets for antitumor strategies. (PubMedID: 22390767) Current pharmaceutical design
01/01/2012
The architectural organization of human stem cell cycle regulatory machinery. (PubMedID: 22394165) Current pharmaceutical design
01/01/2012
Neural stem cell niches in health and diseases. (PubMedID: 22394166) Current pharmaceutical design
01/01/2012
Targeting the cancer initiating cell: the ultimate target for cancer therapy. (PubMedID: 22394167) Current pharmaceutical design
01/01/2012
The use of proteomics for systematic analysis of normal and transformed hematopoietic stem cells. (PubMedID: 22397328) Current pharmaceutical design
01/01/2012
Radiovirotherapy: principles and prospects in oncology. (PubMedID: 22397732) Current pharmaceutical design
01/01/2012
Ultrasound contrast agents: updated data on safety profile. (PubMedID: 22435998) Current pharmaceutical design
01/01/2012
The mechanism of carvedilol in experimental viral myocarditis. (PubMedID: 22443630) Current pharmaceutical design
01/01/2012
Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds. (PubMedID: 22443631) Current pharmaceutical design
01/01/2012
Stem cells and tissue regeneration. (PubMedID: 22463767) Current pharmaceutical design
01/01/2012
The impact of the G-quadruplex conformation in the development of novel therapeutic and diagnostic agents. (PubMedID: 22471996) Current pharmaceutical design
01/01/2012
Targeting mTOR pathways in human malignancies. (PubMedID: 22475451) Current pharmaceutical design
01/01/2012
Yeast as a powerful model system for the study of apoptosis regulation by protein kinase C isoforms. (PubMedID: 22475513) Current pharmaceutical design
01/01/2012
Multimerization improves targeting of peptide radio-pharmaceuticals. (PubMedID: 22475514) Current pharmaceutical design
01/01/2012
Tailor-made solutions and multidirectional approach in the combat of degenerative pathologies. (PubMedID: 22512439) Current pharmaceutical design
01/01/2012
Modified polysaccharides as versatile materials in controlled delivery of antidegenerative agents. (PubMedID: 22512440) Current pharmaceutical design
01/01/2012
Advances in hydrogels applied to degenerative diseases. (PubMedID: 22512441) Current pharmaceutical design
01/01/2012
Stem cells as a novel tool for drug screening and treatment of degenerative diseases. (PubMedID: 22512442) Current pharmaceutical design
01/01/2012
Can PET imaging facilitate optimization of cancer therapies? (PubMedID: 22512443) Current pharmaceutical design
01/01/2012
Bioresorbable and nonresorbable polymers for bone tissue engineering. (PubMedID: 22512444) Current pharmaceutical design
01/01/2012
Heparin--a key drug in the treatment of the circulatory degenerative diseases: controlling its action with polymers. (PubMedID: 22512445) Current pharmaceutical design
01/01/2012
Nanostructural hybrid sensitizers for photodynamic therapy. (PubMedID: 22512446) Current pharmaceutical design
01/01/2012
Polymeric nanocarriers and nanoreactors: a survey of possible therapeutic applications. (PubMedID: 22512447) Current pharmaceutical design
01/01/2012
Implantable (bio)polymer coated titanium scaffolds: a review. (PubMedID: 22512448) Current pharmaceutical design
01/01/2012
Pharma-metabolomics in neonatology: is it a dream or a fact? (PubMedID: 22564294) Current pharmaceutical design
01/01/2012
Ibubrofen in the treatment of patent ductus arteriosus in preterm infants: what we know, what we still do not know. (PubMedID: 22564295) Current pharmaceutical design
01/01/2012
Antiplatelet therapy in children: why so different from adults'? (PubMedID: 22564296) Current pharmaceutical design
01/01/2012
The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature. (PubMedID: 22564297) Current pharmaceutical design
01/01/2012
Transient tachypnea of the newborn: the treatment strategies. (PubMedID: 22564298) Current pharmaceutical design
01/01/2012
Hepatic injury to the newborn liver due to drugs. (PubMedID: 22564299) Current pharmaceutical design
01/01/2012
Treatment of disorders characterized by reversible airway obstruction in childhood: are anti-cholinergic agents the answer? (PubMedID: 22564300) Current pharmaceutical design
01/01/2012
New pharmacological approaches in infants with hypoxic-ischemic encephalopathy. (PubMedID: 22564301) Current pharmaceutical design
01/01/2012
Vitamin A in prevention of bronchopulmonary dysplasia. (PubMedID: 22564302) Current pharmaceutical design
01/01/2012
Pharmacokinetics of aminoglycosides in the newborn. (PubMedID: 22564303) Current pharmaceutical design
01/01/2012
Pharmacokinetics of drugs in neonates: pattern recognition beyond compound specific observations. (PubMedID: 22564304) Current pharmaceutical design
01/01/2012
Cells, the tree, medicines and the tailor. (PubMedID: 22564305) Current pharmaceutical design
01/01/2012
Tracking stem cells for cellular therapy in stroke. (PubMedID: 22571604) Current pharmaceutical design
01/01/2012
Conformationally constrained peptides as protein tyrosine kinase inhibitors. (PubMedID: 22571654) Current pharmaceutical design
01/01/2012
Radiolabeled small molecule inhibitors of VEGFR - recent advances. (PubMedID: 22571655) Current pharmaceutical design
01/01/2012
Recent advances in designing substrate-competitive protein kinase inhibitors. (PubMedID: 22571656) Current pharmaceutical design
01/01/2012
Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target. (PubMedID: 22571657) Current pharmaceutical design
01/01/2012
Kinase inhibitor conjugates. (PubMedID: 22571658) Current pharmaceutical design
01/01/2012
Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives. (PubMedID: 22571659) Current pharmaceutical design
01/01/2012
Exploiting substrate recognition for selective inhibition of protein kinases. (PubMedID: 22571660) Current pharmaceutical design
01/01/2012
Selective VEGFR inhibitors for anticancer therapeutics in clinical use and clinical trials. (PubMedID: 22571661) Current pharmaceutical design
01/01/2012
New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors. (PubMedID: 22571662) Current pharmaceutical design
01/01/2012
Molecular dynamics of protein kinase-inhibitor complexes: a valid structural information. (PubMedID: 22571663) Current pharmaceutical design
01/01/2012
Rho kinase inhibitors: potential treatments for diabetes and diabetic complications. (PubMedID: 22571664) Current pharmaceutical design
01/01/2012
Cyclin-dependent kinase inhibitors inspired by roscovitine: purine bioisosteres. (PubMedID: 22571665) Current pharmaceutical design
01/01/2012
Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications. (PubMedID: 22571666) Current pharmaceutical design
01/01/2012
Editorial: Protein kinase inhibitors: current strategies and future prospects. (PubMedID: 22571667) Current pharmaceutical design
01/01/2012
World Health Organization classification of myelodysplastic syndromes. (PubMedID: 22571693) Current pharmaceutical design
01/01/2012
Genome-wide analysis of myelodysplastic syndromes. (PubMedID: 22571694) Current pharmaceutical design
01/01/2012
Implication of microRNAs in the pathogenesis of MDS. (PubMedID: 22571695) Current pharmaceutical design
01/01/2012
5q- syndrome. (PubMedID: 22571696) Current pharmaceutical design
01/01/2012
Immunosuppressive therapy for myelodysplastic syndromes. (PubMedID: 22571697) Current pharmaceutical design
01/01/2012
Utility of DNA methyltransferase inhibitors for the treatment of myelodysplastic syndromes. (PubMedID: 22571698) Current pharmaceutical design
01/01/2012
Lenalidomide for treatment of myelodysplastic syndromes. (PubMedID: 22571699) Current pharmaceutical design
01/01/2012
Approach to new therapeutics: investigation by the use of MDS-derived cell lines. (PubMedID: 22571700) Current pharmaceutical design
01/01/2012
Current status of allogeneic hematopoietic cell transplantation for MDS. (PubMedID: 22571701) Current pharmaceutical design
01/01/2012
Pathophysiological and clinical aspects of iron chelation therapy in MDS. (PubMedID: 22571702) Current pharmaceutical design
01/01/2012
New treatment strategy of the myelodysplastic syndromes. (PubMedID: 22571703) Current pharmaceutical design
01/01/2012
Breaking the barrier in stroke: what should we know? A mini-review. (PubMedID: 22574976) Current pharmaceutical design
01/01/2012
Neurovascular matrix metalloproteinases and the blood-brain barrier. (PubMedID: 22574977) Current pharmaceutical design
01/01/2012
Mechanisms of endogenous endothelial repair in stroke. (PubMedID: 22574978) Current pharmaceutical design
01/01/2012
The role of pericytes in blood-brain barrier function and stroke. (PubMedID: 22574979) Current pharmaceutical design
01/01/2012
Cerebral aneurysm as an exacerbating factor in stroke pathology and a therapeutic target for neuroprotection. (PubMedID: 22574980) Current pharmaceutical design
01/01/2012
Permeating the blood brain barrier and abrogating the inflammation in stroke: implications for stroke therapy. (PubMedID: 22574981) Current pharmaceutical design
01/01/2012
Vascular protection to increase the safety of tissue plasminogen activator for stroke. (PubMedID: 22574982) Current pharmaceutical design
01/01/2012
A series of novel neuroprotective blood brain barrier penetrating flavonoid drugs to treat acute ischemic stroke. (PubMedID: 22574983) Current pharmaceutical design
01/01/2012
Delivery of neurotherapeutics across the blood brain barrier in stroke. (PubMedID: 22574984) Current pharmaceutical design
01/01/2012
CD36 as a therapeutic target for endothelial dysfunction in stroke. (PubMedID: 22574985) Current pharmaceutical design
01/01/2012
Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells. (PubMedID: 22574986) Current pharmaceutical design
01/01/2012
Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. (PubMedID: 22574987) Current pharmaceutical design
01/01/2012
Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy. (PubMedID: 22591383) Current pharmaceutical design
01/01/2012
Chronic lymphocytic leukemia therapy: beyond chemoimmunotherapy. (PubMedID: 22591384) Current pharmaceutical design
01/01/2012
Immune dysfunction in chronic lymphocytic leukemia: the role for immunotherapy. (PubMedID: 22591385) Current pharmaceutical design
01/01/2012
Novel insights in molecular mechanisms of CLL. (PubMedID: 22591386) Current pharmaceutical design
01/01/2012
Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. (PubMedID: 22591387) Current pharmaceutical design
01/01/2012
Editorial: the importance of rational chemotherapy of chronic lymphocytic leukemia. (PubMedID: 22591388) Current pharmaceutical design
01/01/2012
The role of B cell receptor stimulation in CLL pathogenesis. (PubMedID: 22591389) Current pharmaceutical design
01/01/2012
Therapy of elderly/comorbid patients with chronic lymphocytic leukemia. (PubMedID: 22591390) Current pharmaceutical design
01/01/2012
Review of dose-intense platinum and/or paclitaxel containing chemotherapy in advanced and recurrent epithelial ovarian cancer. (PubMedID: 22591417) Current pharmaceutical design
01/01/2012
Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer. (PubMedID: 22591418) Current pharmaceutical design
01/01/2012
Role of farletuzumab in epithelial ovarian carcinoma. (PubMedID: 22591419) Current pharmaceutical design
01/01/2012
The role of bevacizumab in advanced epithelial ovarian cancer. (PubMedID: 22591420) Current pharmaceutical design
01/01/2012
Trabectedin as a new chemotherapy option in the treatment of relapsed platinum sensitive ovarian cancer. (PubMedID: 22591421) Current pharmaceutical design
01/01/2012
Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence. (PubMedID: 22591422) Current pharmaceutical design
01/01/2012
The role of PARP inhibitors in the treatment of ovarian carcinomas. (PubMedID: 22591423) Current pharmaceutical design
01/01/2012
Multiple VEGF family members are simultaneously expressed in ovarian cancer: a proposed model for bevacizumab resistance. (PubMedID: 22591424) Current pharmaceutical design
01/01/2012
Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen. (PubMedID: 22591425) Current pharmaceutical design
01/01/2012
Advances in epithelial ovarian cancer therapy. (PubMedID: 22591426) Current pharmaceutical design
01/01/2012
Choline analogues in malaria chemotherapy. (PubMedID: 22607139) Current pharmaceutical design
01/01/2012
Towards histone deacetylase inhibitors as new antimalarial drugs. (PubMedID: 22607140) Current pharmaceutical design
01/01/2012
Lipoic acid metabolism of Plasmodium--a suitable drug target. (PubMedID: 22607141) Current pharmaceutical design
01/01/2012
The apicoplast: a key target to cure malaria. (PubMedID: 22607142) Current pharmaceutical design
01/01/2012
Novel drug targets in malaria parasite with potential to yield antimalarial drugs with long useful therapeutic lives. (PubMedID: 22607143) Current pharmaceutical design
01/01/2012
Inhibition of protein-protein interactions in Plasmodium falciparum: future drug targets. (PubMedID: 22607144) Current pharmaceutical design
01/01/2012
Antimalarials in the treatment of schistosomiasis. (PubMedID: 22607145) Current pharmaceutical design
01/01/2012
A physico-biochemical study on potential redox-cyclers as antimalarial and anti-schistosomal drugs. (PubMedID: 22607146) Current pharmaceutical design
01/01/2012
Targeting schistosome histone modifying enzymes for drug development. (PubMedID: 22607147) Current pharmaceutical design
01/01/2012
Protein kinases as potential targets for novel anti-schistosomal strategies. (PubMedID: 22607148) Current pharmaceutical design
01/01/2012
The redox biology of schistosome parasites and applications for drug development. (PubMedID: 22607149) Current pharmaceutical design
01/01/2012
Anti citrullinated protein antibodies and mechanism of action of common disease modifying drugs--insights in pathomechanisms of autoimmunity. (PubMedID: 22612739) Current pharmaceutical design
01/01/2012
Biochemical markers of autoimmune diseases of the nervous system. (PubMedID: 22612740) Current pharmaceutical design
01/01/2012
The ambivalent role of apoptosis in experimental autoimmune encephalomyelitis and multiple sclerosis. (PubMedID: 22612741) Current pharmaceutical design
01/01/2012
In vivo imaging of the diseased nervous system: an update. (PubMedID: 22612742) Current pharmaceutical design
01/01/2012
Neurodegeneration and neuroprotection in multiple sclerosis. (PubMedID: 22612743) Current pharmaceutical design
01/01/2012
Therapeutic monitoring of immunotherapies in autoimmune diseases. (PubMedID: 22612744) Current pharmaceutical design
01/01/2012
Autoimmune diseases in gastroenterology. (PubMedID: 22612745) Current pharmaceutical design
01/01/2012
Immune therapy of multiple sclerosis--future strategies. (PubMedID: 22612746) Current pharmaceutical design
01/01/2012
Animal models in neurology: drawbacks and opportunities. (PubMedID: 22612747) Current pharmaceutical design
01/01/2012
An inventory of short term and long term changes in gene expression under interferon ß treatment of relapsing remitting MS patients. (PubMedID: 22612748) Current pharmaceutical design
01/01/2012
Use of intravenous immunoglobulin in the treatment of immune-mediated demyelinating diseases of the nervous system. (PubMedID: 22612749) Current pharmaceutical design
01/01/2012
Psychoneuroimmunology - psyche and autoimmunity. (PubMedID: 22612750) Current pharmaceutical design
01/01/2012
Monoclonal antibodies in the treatment of neuroimmunological diseases. (PubMedID: 22612751) Current pharmaceutical design
01/01/2012
Immunological aspects of the complex regional pain syndrome (CRPS). (PubMedID: 22612752) Current pharmaceutical design
01/01/2012
Current immune therapies of autoimmune disease of the nervous system with special emphasis to multiple sclerosis. (PubMedID: 22612753) Current pharmaceutical design
01/01/2012
Modern therapeutic strategies for autoimmune diseases. (PubMedID: 22612754) Current pharmaceutical design
01/01/2012
Management of spasticity in progressive multiple sclerosis: efficacy of repeated intrathecal triamcinolone acetonide administration. (PubMedID: 22612755) Current pharmaceutical design
01/01/2012
Paraneoplastic neurological syndromes--diagnosis and management. (PubMedID: 22612756) Current pharmaceutical design
01/01/2012
Diagnostics and therapy of antineutrophil cytoplasmic antibody (ANCA) associated vasculitides. (PubMedID: 22612757) Current pharmaceutical design
01/01/2012
The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO family. (PubMedID: 22621244) Current pharmaceutical design
01/01/2012
The effect of first-in-class small molecule RhoA inhibitor, HL07, on the phenylephrine-induced artery contraction. (PubMedID: 22621254) Current pharmaceutical design
01/01/2012
Future preventive and therapeutic targets for transfusion-related acute lung injury. (PubMedID: 22621267) Current pharmaceutical design
01/01/2012
Prevention of non-immune mediated transfusion-related acute lung injury; from blood bank to patient. (PubMedID: 22621268) Current pharmaceutical design
01/01/2012
Coagulopathy as a therapeutic target for TRALI: rationale and possible sites of action. (PubMedID: 22621269) Current pharmaceutical design
01/01/2012
Platelet-neutrophil interactions as a target for prevention and treatment of transfusion-related acute lung injury. (PubMedID: 22621270) Current pharmaceutical design
01/01/2012
Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor. (PubMedID: 22621271) Current pharmaceutical design
01/01/2012
Transfusion-related acute lung injury: an overview. (PubMedID: 22621272) Current pharmaceutical design
01/01/2012
Prevention of immune-mediated transfusion-related acute lung injury; from bloodbank to patient. (PubMedID: 22621273) Current pharmaceutical design
01/01/2012
State of the art management of transfusion-related acute lung injury (TRALI). (PubMedID: 22621274) Current pharmaceutical design
01/01/2012
Preventive and therapeutic strategies for transfusion-related acute lung injury. (PubMedID: 22621275) Current pharmaceutical design
01/01/2012
Context-dependent action of transforming growth factor ß family members on normal and cancer stem cells. (PubMedID: 22630079) Current pharmaceutical design
01/01/2012
Deregulated bone morphogenetic protein receptor signaling underlies fibrodysplasia ossificans progressiva. (PubMedID: 22630080) Current pharmaceutical design
01/01/2012
The TGF-ß signaling pathway as a pharmacological target in a hepatocellular carcinoma. (PubMedID: 22630081) Current pharmaceutical design
01/01/2012
TGF-beta: a master switch in tumor immunity. (PubMedID: 22630082) Current pharmaceutical design
01/01/2012
BMPS and liver: more questions than answers. (PubMedID: 22630083) Current pharmaceutical design
01/01/2012
Cellular players in lung fibrosis. (PubMedID: 22630084) Current pharmaceutical design
01/01/2012
TGFß signaling in liver regeneration. (PubMedID: 22630085) Current pharmaceutical design
01/01/2012
TGF-beta inihibitor-loaded polyelectrolyte multilayers capsules for sustained targeting of hepatocarcinoma cells. (PubMedID: 22630086) Current pharmaceutical design
01/01/2012
TGF-ß in epithelial to mesenchymal transition and metastasis of liver carcinoma. (PubMedID: 22630087) Current pharmaceutical design
01/01/2012
Editorial: TGF-ß1 in pre-malignant and malignant liver disease. (PubMedID: 22630088) Current pharmaceutical design
01/01/2012
Current dental adhesives systems. A narrative review. (PubMedID: 22632386) Current pharmaceutical design
01/01/2012
Medium-term culture of primary oral squamous cell carcinoma in a three- dimensional model: effects on cell survival following topical 5-fluororacile delivery by drug-loaded matrix tablets. (PubMedID: 22632387) Current pharmaceutical design
01/01/2012
Probiotics and oral health. (PubMedID: 22632388) Current pharmaceutical design
01/01/2012
Buccal delivery of methimazole as an alternative means for improvement of drug bioavailability: permeation studies and matrix system design. (PubMedID: 22632389) Current pharmaceutical design
01/01/2012
Medium-term culture of normal human oral mucosa: a novel three-dimensional model to study the effectiveness of drugs administration. (PubMedID: 22632390) Current pharmaceutical design
01/01/2012
Established and novel approaches for the management of hyposalivation and xerostomia. (PubMedID: 22632391) Current pharmaceutical design
01/01/2012
Adverse drug reactions in the oral cavity. (PubMedID: 22632392) Current pharmaceutical design
01/01/2012
Oral HPV infection: current strategies for prevention and therapy. (PubMedID: 22632393) Current pharmaceutical design
01/01/2012
Topical therapies for oral lichen planus management and their efficacy: a narrative review. (PubMedID: 22632394) Current pharmaceutical design
01/01/2012
Mucoadhesive polymers for oral transmucosal drug delivery: a review. (PubMedID: 22632395) Current pharmaceutical design
01/01/2012
The use of human allogenic graft (HBA) for maxillary bone regeneration: review of literature and case reports. (PubMedID: 22632396) Current pharmaceutical design
01/01/2012
Topical fluoride for preventing dental caries in children and adolescents. (PubMedID: 22632397) Current pharmaceutical design
01/01/2012
Innovations in endodontic filling materials: guttapercha vs Resilon. (PubMedID: 22632398) Current pharmaceutical design
01/01/2012
Novel non-invasive adjunctive techniques for early oral cancer diagnosis and oral lesions examination. (PubMedID: 22632399) Current pharmaceutical design
01/01/2012
Synthetic lethality and PARP-inhibitors in oral and head & neck cancer. (PubMedID: 22632400) Current pharmaceutical design
01/01/2012
Editorial: Bio-pharmaceutics and materials in oral cavity. (PubMedID: 22632401) Current pharmaceutical design
01/01/2012
On the psychotropic effects of carbon dioxide. (PubMedID: 22632467) Current pharmaceutical design
01/01/2012
Genetics of anxiety disorders - status quo and quo vadis. (PubMedID: 22632468) Current pharmaceutical design
01/01/2012
Pharmacological innovations for posttraumatic stress disorder and medication- enhanced psychotherapy. (PubMedID: 22632469) Current pharmaceutical design
01/01/2012
Disorder-specific emotional imagery for differential and quantitative assessment of agoraphobia. (PubMedID: 22632470) Current pharmaceutical design
01/01/2012
The role of life events and HPA axis in anxiety disorders: a review. (PubMedID: 22632471) Current pharmaceutical design
01/01/2012
D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update. (PubMedID: 22632472) Current pharmaceutical design
01/01/2012
Stress response regulation in panic disorder. (PubMedID: 22632473) Current pharmaceutical design
01/01/2012
Neuropeptides as therapeutic targets in anxiety disorders. (PubMedID: 22632474) Current pharmaceutical design
01/01/2012
Neuroimaging of serotonin system in anxiety disorders. (PubMedID: 22632475) Current pharmaceutical design
01/01/2012
Panicogens in patients with Post-Traumatic Stress Disorder (PTSD). (PubMedID: 22632476) Current pharmaceutical design
01/01/2012
Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder. (PubMedID: 22632477) Current pharmaceutical design
01/01/2012
Differences in saccadic eye movements in subjects at high and low risk for panic disorder. (PubMedID: 22632478) Current pharmaceutical design
01/01/2012
Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke. (PubMedID: 22632606) Current pharmaceutical design
01/01/2012
Target-based anti-angiogenic therapy in breast cancer. (PubMedID: 22632607) Current pharmaceutical design
01/01/2012
Molecular link mechanisms between inflammation and cancer. (PubMedID: 22632748) Current pharmaceutical design
01/01/2012
Tobacco, inflammation, and respiratory tract cancer. (PubMedID: 22632749) Current pharmaceutical design
01/01/2012
Reactive oxygen species, inflammation, and lung diseases. (PubMedID: 22632750) Current pharmaceutical design
01/01/2012
Pharmacological control of autophagy: therapeutic perspectives in inflammatory bowel disease and colorectal cancer. (PubMedID: 22632751) Current pharmaceutical design
01/01/2012
Non-steroidal anti-inflammatory drugs and melanoma. (PubMedID: 22632752) Current pharmaceutical design
01/01/2012
TGF-ß1 signalling, connecting aberrant inflammation and colorectal tumorigenesis. (PubMedID: 22632753) Current pharmaceutical design
01/01/2012
Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence. (PubMedID: 22632754) Current pharmaceutical design
01/01/2012
Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer. (PubMedID: 22632755) Current pharmaceutical design
01/01/2012
Molecules of natural origin, semi-synthesis and synthesis with anti-inflammatory and anticancer utilities. (PubMedID: 22632756) Current pharmaceutical design
01/01/2012
pH-Sensitive polymeric micelles for programmable drug and gene delivery. (PubMedID: 22632817) Current pharmaceutical design
01/01/2012
The growth hormone secretagogue receptor (Ghs-R). (PubMedID: 22632856) Current pharmaceutical design
01/01/2012
Ghrelin and motilin in the gastrointestinal system. (PubMedID: 22632857) Current pharmaceutical design
01/01/2012
The role of NPY and ghrelin in anorexia nervosa. (PubMedID: 22632858) Current pharmaceutical design
01/01/2012
The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism. (PubMedID: 22632859) Current pharmaceutical design
01/01/2012
Clinical application of ghrelin. (PubMedID: 22632860) Current pharmaceutical design
01/01/2012
Cachexia and oxidative stress in cancer: an innovative therapeutic management. (PubMedID: 22632861) Current pharmaceutical design
01/01/2012
The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world. (PubMedID: 22632862) Current pharmaceutical design
01/01/2012
Rikkunshito and ghrelin secretion. (PubMedID: 22632863) Current pharmaceutical design
01/01/2012
A review of traditional Japanese medicines and their potential mechanism of action. (PubMedID: 22632864) Current pharmaceutical design
01/01/2012
Neurohormones, rikkunshito and hypothalamic neurons interactively control appetite and anorexia. (PubMedID: 22632865) Current pharmaceutical design
01/01/2012
Cachexia and herbal medicine: perspective. (PubMedID: 22632866) Current pharmaceutical design
01/01/2012
Recent advances in formation, properties, and applications of polymersomes. (PubMedID: 22632981) Current pharmaceutical design
01/01/2012
Recent advance in the design of small molecular modulators of estrogen-related receptors. (PubMedID: 22632982) Current pharmaceutical design
01/01/2012
Removal of the tag from His-tagged ILYd4, a human CD59 inhibitor, significantly improves its physical properties and its activity. (PubMedID: 22642361) Current pharmaceutical design
01/01/2012
Insights on biology and pathology of HIF-1a/-2a, TGFß/BMP, Wnt/ß-catenin, and NF-?B pathways in osteoarthritis. (PubMedID: 22646092) Current pharmaceutical design
01/01/2012
New therapeutic strategies for cancer and neurodegeneration emerging from yeast cell-based systems. (PubMedID: 22650181) Current pharmaceutical design
01/01/2012
Using fragment-based technologies to target protein-protein interactions. (PubMedID: 22650253) Current pharmaceutical design
01/01/2012
P53 mdm2 inhibitors. (PubMedID: 22650254) Current pharmaceutical design
01/01/2012
Protein-protein docking and hot-spot prediction for drug discovery. (PubMedID: 22650255) Current pharmaceutical design
01/01/2012
Small-molecule inhibitors of protein-protein interactions: how to mimic a protein partner. (PubMedID: 22650256) Current pharmaceutical design
01/01/2012
Modulating protein-protein interactions: from structural determinants of binding to druggability prediction to application. (PubMedID: 22650257) Current pharmaceutical design
01/01/2012
Druggability of dynamic protein-protein interfaces. (PubMedID: 22650258) Current pharmaceutical design
01/01/2012
Protein-protein interfaces integrated into interaction networks: implications on drug design. (PubMedID: 22650259) Current pharmaceutical design
01/01/2012
A leap into the chemical space of protein-protein interaction inhibitors. (PubMedID: 22650260) Current pharmaceutical design
01/01/2012
Protein-protein interactions: network analysis and applications in drug discovery. (PubMedID: 22650261) Current pharmaceutical design
01/01/2012
Pharmacophore modelling as a virtual screening tool for the discovery of small molecule protein-protein interaction inhibitors. (PubMedID: 22650262) Current pharmaceutical design
01/01/2012
Editorial: Toward the design of drugs on protein-protein interactions. (PubMedID: 22650263) Current pharmaceutical design
01/01/2012
Translational research in oncology: the need of additional in vitro preclinical testing methods for new drugs. (PubMedID: 22663553) Current pharmaceutical design
01/01/2012
Electrochemotherapy: progress and prospects. (PubMedID: 22663554) Current pharmaceutical design
01/01/2012
QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum. (PubMedID: 22670592) Current pharmaceutical design
01/01/2012
Neurobiology of depression and novel antidepressant drug targets. (PubMedID: 22681160) Current pharmaceutical design
01/01/2012
Sleep and antidepressant treatment. (PubMedID: 22681161) Current pharmaceutical design
01/01/2012
Therapeutic drug monitoring for antidepressant drug treatment. (PubMedID: 22681162) Current pharmaceutical design
01/01/2012
Lack of data on depression-like states and antidepressant pharmacotherapy in patients with epilepsy: randomised controlled trials are badly needed. (PubMedID: 22681163) Current pharmaceutical design
01/01/2012
Stress, depression and antidepressant treatment options in patients suffering from multiple sclerosis. (PubMedID: 22681164) Current pharmaceutical design
01/01/2012
The role of transcranial magnetic stimulation in treatment-resistant depression: a review. (PubMedID: 22681165) Current pharmaceutical design
01/01/2012
Genetics and personalized medicine in antidepressant treatment. (PubMedID: 22681166) Current pharmaceutical design
01/01/2012
Epigenetics, depression and antidepressant treatment. (PubMedID: 22681167) Current pharmaceutical design
01/01/2012
The role of oxidative stress in depressive disorders. (PubMedID: 22681168) Current pharmaceutical design
01/01/2012
Glucose metabolism and antidepressant medication. (PubMedID: 22681169) Current pharmaceutical design
01/01/2012
Inflammatory cytokines, growth factors, and depression. (PubMedID: 22681170) Current pharmaceutical design
01/01/2012
Health service utilization and costs of depressive symptoms in late life - a systematic review. (PubMedID: 22681171) Current pharmaceutical design
01/01/2012
Choice of treatment with antidepressants: influencing factors. (PubMedID: 22681172) Current pharmaceutical design
01/01/2012
The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. (PubMedID: 22681173) Current pharmaceutical design
01/01/2012
Editorial: treatment with antidepressants. (PubMedID: 22681174) Current pharmaceutical design
01/01/2012
A computational study of the oligosaccharide binding sites in the lectin-like domain of Tumor Necrosis Factor and the TNF-derived TIP peptide. (PubMedID: 22697478) Current pharmaceutical design
01/01/2012
The yin and yang of cannabis-induced psychosis: the actions of ?(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia. (PubMedID: 22716133) Current pharmaceutical design
01/01/2012
The effect of cannabis on perception of time: a critical review. (PubMedID: 22716134) Current pharmaceutical design
01/01/2012
Treatment of cannabis use among people with psychotic disorders: a critical review of randomised controlled trials. (PubMedID: 22716135) Current pharmaceutical design
01/01/2012
Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies. (PubMedID: 22716136) Current pharmaceutical design
01/01/2012
Patient's perceptions of the cannabis-psychosis link--a systematic review. (PubMedID: 22716137) Current pharmaceutical design
01/01/2012
Cannabis use and duration of untreated psychosis: a systematic review and meta-analysis. (PubMedID: 22716138) Current pharmaceutical design
01/01/2012
Genetic variation underlying psychosis-inducing effects of cannabis: critical review and future directions. (PubMedID: 22716139) Current pharmaceutical design
01/01/2012
Resting state abnormalities in psychosis compared to acute cannabinoids and opioids challenges: a systematic review of functional imaging studies. (PubMedID: 22716140) Current pharmaceutical design
01/01/2012
Cannabis in the arm: what can we learn from intravenous cannabinoid studies? (PubMedID: 22716141) Current pharmaceutical design
01/01/2012
Neurophysiological effects of cannabinoids: implications for psychosis research. (PubMedID: 22716142) Current pharmaceutical design
01/01/2012
Potential protective effects of cannabidiol on neuroanatomical alterations in cannabis users and psychosis: a critical review. (PubMedID: 22716143) Current pharmaceutical design
01/01/2012
Why do psychotic patients use cannabis? Case series. (PubMedID: 22716144) Current pharmaceutical design
01/01/2012
Psychopharmacological boundaries of schizophrenia with comorbid cannabis use disorder: a critical review. (PubMedID: 22716145) Current pharmaceutical design
01/01/2012
Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia. (PubMedID: 22716146) Current pharmaceutical design
01/01/2012
Anandamide dysfunction in prodromal and established psychosis. (PubMedID: 22716147) Current pharmaceutical design
01/01/2012
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. (PubMedID: 22716148) Current pharmaceutical design
01/01/2012
Cannabis use and psychosis: theme introduction. (PubMedID: 22716149) Current pharmaceutical design
01/01/2012
The association between cannabis use and earlier age at onset of schizophrenia and other psychoses: meta-analysis of possible confounding factors. (PubMedID: 22716150) Current pharmaceutical design
01/01/2012
Gene-environment interactions underlying the effect of cannabis in first episode psychosis. (PubMedID: 22716151) Current pharmaceutical design
01/01/2012
Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies. (PubMedID: 22716152) Current pharmaceutical design
01/01/2012
Antipsychotic-like effects of cannabidiol and rimonabant: systematic review of animal and human studies. (PubMedID: 22716153) Current pharmaceutical design
01/01/2012
Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox. (PubMedID: 22716154) Current pharmaceutical design
01/01/2012
Subjective and physiological effects of oromucosal sprays containing cannabinoids (nabiximols): potentials and limitations for psychosis research. (PubMedID: 22716155) Current pharmaceutical design
01/01/2012
Neurocognitive functioning and cannabis use in schizophrenia. (PubMedID: 22716156) Current pharmaceutical design
01/01/2012
Can cannabis increase the suicide risk in psychosis? A critical review. (PubMedID: 22716157) Current pharmaceutical design
01/01/2012
Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis. (PubMedID: 22716158) Current pharmaceutical design
01/01/2012
The endocannabinoid system and schizophrenia: integration of evidence. (PubMedID: 22716159) Current pharmaceutical design
01/01/2012
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. (PubMedID: 22716160) Current pharmaceutical design
01/01/2012
Cannabis and psychosis: targeting potential treatments. (PubMedID: 22716161) Current pharmaceutical design
01/01/2012
TNF-a/cycloheximide-induced oxidative stress and apoptosis in murine intestinal epithelial MODE-K cells. (PubMedID: 22721505) Current pharmaceutical design
01/01/2012
Current strategies for drug development against major human parasites: malaria and schistosomiasis. (PubMedID: 22721585) Current pharmaceutical design
01/01/2012
The role of platelets in athero-thrombotic events. (PubMedID: 22724408) Current pharmaceutical design
01/01/2012
Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance. (PubMedID: 22724409) Current pharmaceutical design
01/01/2012
Clinical use of aspirin in ischemic heart disease: past, present and future. (PubMedID: 22724410) Current pharmaceutical design
01/01/2012
Clinical use of clopidogrel. (PubMedID: 22724411) Current pharmaceutical design
01/01/2012
Development and clinical use of prasugrel and ticagrelor. (PubMedID: 22724412) Current pharmaceutical design
01/01/2012
Antiplatelet and anticoagulation strategies in the prevention and treatment of ischemic stroke. (PubMedID: 22724413) Current pharmaceutical design
01/01/2012
Platelet function testing in atherothrombotic disease. (PubMedID: 22724414) Current pharmaceutical design
01/01/2012
Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease. (PubMedID: 22724415) Current pharmaceutical design
01/01/2012
Pharmacogenetics of the antiplatelet effect of aspirin. (PubMedID: 22724416) Current pharmaceutical design
01/01/2012
Pharmacogenetics of clopidogrel. (PubMedID: 22724417) Current pharmaceutical design
01/01/2012
Platelet turnover in atherothrombotic disease. (PubMedID: 22724418) Current pharmaceutical design
01/01/2012
Risk of bleeding related to antithrombotic treatment in cardiovascular disease. (PubMedID: 22724419) Current pharmaceutical design
01/01/2012
Tailoring antiplatelet therapy: a step toward individualized therapy to improve clinical outcome? (PubMedID: 22724420) Current pharmaceutical design
01/01/2012
Editorial: Paving the way for improved antiplatelet therapy. (PubMedID: 22724421) Current pharmaceutical design
01/01/2012
Bioactive peptides: are there more antihypertensive mechanisms beyond ACE inhibition? (PubMedID: 22725850) Current pharmaceutical design
01/01/2012
Personalized therapies in pediatric inflammatory and autoimmune diseases. (PubMedID: 22726111) Current pharmaceutical design
01/01/2012
The dietary paradox in food allergy: yesterday's mistakes, today's evidence and lessons for tomorrow. (PubMedID: 22726112) Current pharmaceutical design
01/01/2012
Gluten-dependent intestinal autoimmune response. (PubMedID: 22726113) Current pharmaceutical design
01/01/2012
Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. (PubMedID: 22726114) Current pharmaceutical design
01/01/2012
Defective and excessive immunities in pediatric diseases. (PubMedID: 22726115) Current pharmaceutical design
01/01/2012
NF-?B as a target for modulating inflammatory responses. (PubMedID: 22726116) Current pharmaceutical design
01/01/2012
From bone marrow transplantation to cellular therapies: possible therapeutic strategies in managing autoimmune disorders. (PubMedID: 22726117) Current pharmaceutical design
01/01/2012
Potential role of TRAIL in the management of autoimmune diabetes mellitus. (PubMedID: 22726118) Current pharmaceutical design
01/01/2012
Editorial: innovative therapeutic approaches for the treatment of pediatric autoimmune and inflammatory diseases. (PubMedID: 22726119) Current pharmaceutical design
01/01/2012
The blood brain barrier in stroke. (PubMedID: 22734824) Current pharmaceutical design
01/01/2012
Carotenoids and cardiovascular risk. (PubMedID: 22747421) Current pharmaceutical design
01/01/2012
PDE5 inhibitor treatment options for urologic and non-urologic indications: 2012 update. (PubMedID: 22747425) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: opioid-induced respiratory depression. (PubMedID: 22747535) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: peripheral opioid effects on inflammation and wound healing. (PubMedID: 22747536) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: the interaction of opioids with bone and joints. (PubMedID: 22747537) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation. (PubMedID: 22747538) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: opioids and the endocrine system. (PubMedID: 22747539) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: the cognitive effects of opioids in chronic pain of malignant and non-malignant origin. An update. (PubMedID: 22747540) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: cardiovascular effects of opioids and their receptor systems. (PubMedID: 22747541) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: opioids' effects on sleep (including sleep apnea). (PubMedID: 22747542) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression. (PubMedID: 22747543) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal? (PubMedID: 22747544) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: peripheral opioid receptors as promising targets for future anti-pruritic therapies. (PubMedID: 22747545) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: factors relevant to opioid abuse and abuse- deterrent formulations. (PubMedID: 22747546) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: neuroprotection in the retina. (PubMedID: 22747547) Current pharmaceutical design
01/01/2012
Non-analgesic effects of opioids: interactions between opioids and other drugs. (PubMedID: 22747548) Current pharmaceutical design
01/01/2012
Editorial: non-analgesic effects of opioids: the dark side of the moon. (PubMedID: 22747549) Current pharmaceutical design
01/01/2012
Perioperative glycemic management in insulin pump patients undergoing noncardiac surgery. (PubMedID: 22762462) Current pharmaceutical design